Articles

The Food and Drug Administration on Thursday approved updated COVID-19 vaccines made by Pfizer Inc. and Moderna Inc., as a summer wave of the virus is still rolling across the country.

I’m trying to work out if I’ve ever heard as much nonsense in such a short period of time as I’m hearing right now about the Biden-Harris plan to tax unrealized capital gains.

Second-quarter earnings beat estimates and company guides to top of full-year range

Over the past two years, retailers have had a tougher time getting inflation-battered shoppers to spend at their stores. But for the biggest chains, some analysts say, that’s become less of a problem.

The Democratic vice-presidential candidate’s campaign confirmed Walz’s withdrawal from a 401(k)-type plan.

Annuity rates won’t last.

Gold traded sharply lower on Thursday, with strength in the U.S. dollar contributing to weakness in prices of the precious metal just two days after it marked a fresh record high.

Stocks have usually climbed when Fed Chair Jerome Powell speaks at the Jackson Hole Economic Symposium — with two big exceptions.

Estée Lauder drew an upgrade to overweight from neutral at Piper Sandler on Thursday as analyst Korinne Wolfmeyer said she’s more bullish on the beauty giant after its stock has lost more than a third of its value so far this year.

Charles Lemonides of ValueWorks makes the case that Amazon is a bargain stock on a sum-of-the-parts basis.

Tom Lee, managing partner and head of research at Fundstrat Global Advisors told CNBC’s “Squawk Box” that the Federal Reserve’s reliance on economic data to make interest-rate decisions may end up hurting the U.S. economy.

The 30-year mortgage rate is averaging 6.46%, Freddie Mac said in its latest weekly survey on Thursday.